227
Views
78
CrossRef citations to date
0
Altmetric
Research Article

Anti-inflammatory role of naringenin in rats with ethanol induced liver injury

, , &
Pages 568-576 | Received 12 May 2012, Accepted 24 Jun 2012, Published online: 01 Jul 2012

References

  • Alarcon LH, Taylor BS, Billiar TR. 1997. The role of nitric oxide in liver pathophysiology. In: Boyer JL, Ockner RK, eds. Progress in liver disease, vol 15. Philadelphia: WB Saunders. 85–108.
  • Benherlal PS, Arumughan C. 2008. Studies on modulation of DNA integrity in Fenton’s system by phytochemicals. Mutat Res 648:1–8.
  • Birt DF, Hendrich S, Wang W. 2001. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 90:157–177.
  • Cairo G, Pietrangelo A. 1995. Nitric-oxide-mediated activation of iron-regulatory protein controls hepatic iron metabolism during acute inflammation. Eur J Biochem 232:358–363.
  • Carmela L, Alessandra F. 2003. Oxidative stress in viral and alcoholic hepatitis. Free. Radic. Biol. Med. 34:1–10.
  • Choi JS, Park KY, Moon SH, Rhee SH, Young HS. 1994. Antimutagenic effect of plant flavonoids in the Salmonella assay system. Arch Pharm Res 17:71–75.
  • Drysdale JW, Munro HN. 1965. Small-scale isolation of ferritin for the assay of the incorporation of 14c-labelled amino acids. Biochem J 95:851–858.
  • Enomoto N, Ikejima K, Yamashina S, Enomoto A, Nishiura T, Nishimura T, Brenner DA, Schemmer P, Bradford BU, Rivera CA, Zhong Z, Thurman RG. 2000. Kupffer cell-derived prostaglandin E(2) is involved in alcohol-induced fat accumulation in rat liver. Am J Physiol Gastrointest Liver Physiol 279:G100–G106.
  • Erlund I, Meririnne E, Alfthan G, Aro A. 2001. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr 131:235–241.
  • Fang T, Wang Y, Ma Y, Su W, Bai Y, Zhao P. 2006. A rapid LC/MS/MS quantitation assay for naringin and its two metabolites in rats plasma. J Pharm Biomed Anal 40:454–459.
  • Fletcher LM, Halliday JW, Powell LW. 1999. Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin. J Gastroenterol Hepatol 14:202–214.
  • Goldberg DM, Watts C. 1965. Serum enzyme changes as evidence of liver reaction to oral alcohol. Gastroenterology 49:256–261.
  • Goossens V, Grooten J, De Vos K, Fiers W. 1995. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 92:8115–8119.
  • Hämäläinen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. 2007. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007:45673.
  • Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, McClain CJ. 1992. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 119:547–552.
  • Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T. 2001. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88:E14–E22.
  • Hirai S, Kim YI, Goto T, Kang MS, Yoshimura M, Obata A, Yu R, Kawada T. 2007. Inhibitory effect of naringenin chalcone on inflammatory changes in the interaction between adipocytes and macrophages. Life Sci 81:1272–1279.
  • Hoek JB. 1999. Endotoxin and alcoholic liver disease: tolerance and susceptibility. Hepatology 29:1602–1604.
  • Holden JM, Bhagwat SA, Patterson KY. 2002. Development of a multi-nutrient data quality evaluation system. J. Food. Comp. Anal. 15:339–348.
  • Hwang TL, Yang JT, Lau YT. 1986. Arginine-nitric oxide pathway in plasma membrane of rat hepatocytes during early and late sepsis. Crit Care Med 1999; 27:137l B, Gutteridge JMC. Arch. Biochem. biophys. 246:501.
  • Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG. 1997. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26:1530–1537.
  • Jaeschke H. 1997. Chemokines and liver inflammation: the battle between pro- and anti-inflammatory mediators. Hepatology 25:252–253.
  • Jayaraman J, Veerappan M, Namasivayam N. 2009. Potential beneficial effect of naringenin on lipid peroxidation and antioxidant status in rats with ethanol-induced hepatotoxicity. J Pharm Pharmacol 61:1383–1390.
  • Jeyasekhar P, Mohanan PV, Rathinam K. 1997. Hepatoprotective activity of ethyl acetate extract of Acacia catechu. Indian. Pharmacol. 29:426–428.
  • Jokelainen K, Reinke LA, Nanji AA. 2001. Nf-kappab activation is associated with free radical generation and endotoxemia and precedes pathological liver injury in experimental alcoholic liver disease. Cytokine 16:36–39.
  • Kamimura S, Tsukamoto H. 1995. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 22:1304–1309.
  • Kaplowitz N, Tsukamoto H. 1996. Oxidative stress and liver disease. Prog Liver Dis 14:131–159.
  • Kayama F, Yoshida T, Elwell MR, Luster MI. 1995. Role of tumor necrosis factor-alpha in cadmium-induced hepatotoxicity. Toxicol Appl Pharmacol 131:224–234.
  • Lee MH, Yoon S, Moon JO. 2004. The flavonoid naringenin inhibits dimethylnitrosamine-induced liver damage in rats. Biol Pharm Bull 27:72–76.
  • Li SW, Gong JP, Wu CX, Shi YJ, Liu CA. 2002. Lipopolysaccharide induced synthesis of CD14 proteins and its gene expression in hepatocytes during endotoxemia. World J Gastroenterol 8:124–127.
  • Lieber CS. 2000. Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol 32:113–128.
  • Lyu SY, Park WB. 2005. Production of cytokine and NO by RAW 264.7 macrophages and PBMC in vitro incubation with flavonoids. Arch Pharm Res 28:573–581.
  • Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL. 1990. Plasma tumor necrosis factor a predicts decreased long term survival in severe alcoholic hepatitis. Alcohol. Clin. Exp. Res. 14:255–259.
  • Mira L, Fernandez MT, Santos M, Rocha R, Florêncio MH, Jennings KR. 2002. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 36:1199–1208.
  • Miranda-Mendez A, Lugo-Baruqui A, Armendariz-Borunda J. 2010. Molecular basis and current treatment for alcoholic liver disease. Int J Environ Res Public Health 7:1872–1888.
  • Moncada S, Palmer RM, Higgs EA. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142.
  • Nanji AA, Jokelainen K, Rahemtulla A, Miao L, Fogt F, Matsumoto H, Tahan SR, Su GL. 1999. Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 30:934–943.
  • Nanji AA. 2002. Role of Kupffer cells in alcoholic hepatitis. Alcohol 27:13–15.
  • Nanji AA, Zakim D, Rahemtulla A, Daly T, Miao L, Zhao S, Khwaja S, Tahan SR, Dannenberg AJ. 1997. Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology 26:1538–1545.
  • Nussler AK, Billiar TR. 1993. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 54:171–178.
  • Pascoe A, Kerlin P, Jones D. 2000. Spur cell anemia explains the iron overload in advanced cirrhosis (C282Y negative). Hepatology 32:159.
  • Ramsay WNM. 1958. In: Advances in Clinical chemistry, (eds, Sobaka H, steward LP, Academic press, New York. p. 1.
  • Raso GM, Meli R, Di Carlo G, Pacilio M, Di Carlo R. 2001. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci 68:921–931.
  • Reitman S, Frankel S. 1957. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28:56–63.
  • Rouach H, Houze P, Orfanelli MT, Gentil M, Bourdon R, Nordmann R. 1990. Effect of acute ethanol administration on the subcellular distribution of iron in rat liver and cerebellum. Biochem Pharmacol 39:1095–1100.
  • Scholz EP, Zitron E, Kiesecker C, Thomas D, Kathöfer S, Kreuzer J, Bauer A, Katus HA, Remppis A, Karle CA, Greten J. 2007. Orange flavonoid hesperetin modulates cardiac hERG potassium channel via binding to amino acid F656. Nutr Metab Cardiovasc Dis 17:666–675.
  • Shi Y, Dai J, Liu H, Li RR, Sun PL, Du Q, Pang LL, Chen Z, Yin KS. 2009. Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-kappaB activity in a murine model of asthma. Can J Physiol Pharmacol 87:729–735.
  • Su GL, Rahemtulla A, Thomas P, Klein RD, Wang SC, Nanji AA. 1998. CD14 and lipopolysaccharide binding protein expression in a rat model of alcoholic liver disease. Am J Pathol 152:841–849.
  • Takahashi T, Kobori M, Shinmoto H, Tsushida T. 1998. Structure-activity relationships of flavonoids and the induction of granulocytic- or monocytic-differentiation in HL60 human myeloid leukemia cells. Biosci Biotechnol Biochem 62:2199–2204.
  • Tsukamoto H, Horne W, Kamimura S, Niemelä O, Parkkila S, Ylä-Herttuala S, Brittenham GM. 1995. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96:620–630.
  • Vafeiadou K, Vauzour D, Lee HY, Rodriguez-Mateos A, Williams RJ, Spencer JP. 2009. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch Biochem Biophys 484:100–109.
  • Valerio LG Jr, Parks T, Petersen DR. 1996. Alcohol mediates increases in hepatic and serum nonheme iron stores in a rat model for alcohol-induced liver injury. Alcohol Clin Exp Res 20:1352–1361.
  • van Acker FA, Schouten O, Haenen GR, van der Vijgh WJ, Bast A. 2000. Flavonoids can replace alpha-tocopherol as an antioxidant. FEBS Lett 473:145–148.
  • Voraberger G, Schäfer R, Stratowa C. 1991. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5’-regulatory region. Induction by cytokines and phorbol ester. J Immunol 147:2777–2786.
  • Watts RN, Richardson DR. 2002. The mechanism of nitrogen monoxide (NO)-mediated iron mobilization from cells. NO intercepts iron before incorporation into ferritin and indirectly mobilizes iron from ferritin in a glutathione-dependent manner. Eur J Biochem 269:3383–3392.
  • Windmer U, Manougue KR, Cerami A, Sherry B. 1993. Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP-2), MIP-1α, members of chemokines superfamily of proinflammatory cytokines. J. Immunol. 150:4996–5012.
  • Yu J, Ip E, Dela Peña A, Hou JY, Sesha J, Pera N, Hall P, Kirsch R, Leclercq I, Farrell GC. 2006. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator. Hepatology 43:826–836.
  • Zhao J, Chen H, Li Y. 2008. Protective effect of bicyclol on acute alcohol-induced liver injury in mice. Eur J Pharmacol 586:322–331.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.